HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joo Seop Chung Selected Research

Highly Active Antiretroviral Therapy (HAART)

9/2017Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
1/2013Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011.
2/2008Report of AIDS-related lymphoma in South Korea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joo Seop Chung Research Topics

Disease

10Neoplasms (Cancer)
01/2019 - 10/2006
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2015 - 08/2007
4Stomach Neoplasms (Stomach Cancer)
01/2019 - 11/2007
4Neutropenia
01/2019 - 04/2010
4Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2013 - 04/2003
3Breast Neoplasms (Breast Cancer)
03/2019 - 07/2012
3Nausea
01/2019 - 07/2014
3Disease Progression
01/2019 - 02/2008
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019 - 07/2010
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2017 - 06/2011
3Infections
07/2016 - 08/2008
3Multiple Myeloma
04/2015 - 03/2011
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2014 - 05/2012
2Anemia
01/2019 - 07/2014
2Vomiting
01/2019 - 02/2016
2Philadelphia Chromosome
12/2017 - 07/2014
2Aplastic Anemia (Anemia, Hypoplastic)
09/2017 - 01/2016
2Acquired Immunodeficiency Syndrome (AIDS)
09/2017 - 01/2013
2Chromosome Aberrations (Chromosome Abnormalities)
04/2015 - 08/2007
2Plasmacytoma
04/2015 - 11/2014
2Lymphoma (Lymphomas)
12/2010 - 04/2010
2Leukemia
06/2009 - 06/2009
1Peripheral Nervous System Diseases (PNS Diseases)
01/2019
1Hypoxia (Hypoxemia)
03/2018
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
09/2017
1Hemolysis
09/2017
1Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1Primary Myelofibrosis (Myelosclerosis)
03/2015
1Essential Thrombocythemia
03/2015
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2015
1Cancer Pain
10/2014
1Pain (Aches)
10/2014
1Breakthrough Pain
10/2014
1Asthenia
07/2014
1Thrombocytopenia (Thrombopenia)
07/2014
1Fatigue
07/2014
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2014

Drug/Important Bio-Agent (IBA)

5Cisplatin (Platino)FDA LinkGeneric
03/2009 - 06/2003
4Etoposide (VP 16)FDA LinkGeneric
01/2015 - 03/2009
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2014 - 06/2008
3Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 11/2007
3Rituximab (Mabthera)FDA Link
05/2012 - 11/2010
3Vincristine (Oncovin)FDA LinkGeneric
05/2012 - 06/2008
3Prednisolone (Predate)FDA LinkGeneric
05/2012 - 06/2008
3Doxorubicin (Adriamycin)FDA LinkGeneric
05/2012 - 06/2008
2Proteins (Proteins, Gene)FDA Link
03/2018 - 01/2011
24- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- trifluoromethylphenyl)- 3- (4- pyrazin- 2- ylpyrimidin- 2- ylamino)benzamideIBA
12/2017 - 07/2014
2Imatinib Mesylate (Gleevec)FDA Link
12/2017 - 06/2011
2Tyrosine Kinase InhibitorsIBA
12/2017 - 07/2014
2Pharmaceutical PreparationsIBA
07/2016 - 07/2014
2Core Binding Factors (Core-Binding Factor)IBA
05/2015 - 06/2010
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2015 - 11/2014
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2014 - 12/2010
2Capecitabine (Xeloda)FDA Link
07/2012 - 01/2009
2Messenger RNA (mRNA)IBA
01/2011 - 08/2007
2LigandsIBA
01/2011 - 10/2006
2GemcitabineFDA Link
04/2010 - 03/2009
2Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2009 - 08/2003
2Alemtuzumab (Campath)FDA Link
08/2008 - 06/2007
1Oxidoreductases (Dehydrogenase)IBA
03/2019
1Progesterone Receptors (Progesterone Receptor)IBA
03/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2019
1Estrogen ReceptorsIBA
03/2019
1Epidermal Growth Factor (EGF)IBA
03/2019
1Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
03/2019
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
03/2019
1Irinotecan (Camptosar)FDA LinkGeneric
01/2019
1Dynamins (Dynamin)IBA
03/2018
1Oxygen (Dioxygen)IBA
03/2018
1erucylphosphocholineIBA
03/2018
1eculizumabFDA Link
09/2017
1cremophor ELIBA
07/2017
1MicellesIBA
07/2017
1genexol-PMIBA
07/2017
1Palonosetron (Aloxi)FDA Link
02/2016
1Granisetron (Kytril)FDA LinkGeneric
02/2016
1Serotonin (5 Hydroxytryptamine)IBA
02/2016
1Hemoglobins (Hemoglobin)IBA
01/2016
1CalreticulinIBA
03/2015
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2015
1Carmustine (FIVB)FDA Link
11/2014
1Busulfan (Busulfex)FDA Link
11/2014
1Melphalan (Alkeran)FDA LinkGeneric
11/2014
1Opioid Analgesics (Opioids)IBA
10/2014
1Hydromorphone (Dilaudid)FDA LinkGeneric
10/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2014
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2013
1IfosfamideFDA LinkGeneric
11/2013
1Hormones (Hormone)IBA
07/2012

Therapy/Procedure

14Drug Therapy (Chemotherapy)
01/2019 - 06/2003
7Therapeutics
01/2019 - 01/2009
4Stem Cell Transplantation
04/2015 - 08/2008
3Radiotherapy
03/2019 - 01/2010
3Highly Active Antiretroviral Therapy (HAART)
09/2017 - 02/2008
3Combination Drug Therapy (Combination Chemotherapy)
03/2009 - 06/2003
2Adjuvant Chemotherapy
03/2019 - 03/2009
2Aftercare (After-Treatment)
06/2011 - 01/2011
2Induction Chemotherapy
06/2009 - 06/2009
1Cell Transplantation
01/2019